Table 1 Anthropometric, biochemical, and echocardiographic variables, blood pressure profile and drugs used by hypertensive patients
Variable | Sample (n = 155) |
|---|---|
Age (years) | 63.2 ± 11.4 |
Gender (male/female) | 66/89 |
Duration of hypertension (years) | 16.0 ± 10.1 |
BMI (kg/m2) | 28.8 ± 4.9 |
Smoker, n (%) | 16 (10.3) |
History of stroke, n (%) | 35 (22.6) |
History of myocardial infarction, n (%) | 7 (4.5) |
LVH, n (%) | 52 (33.5) |
Microalbuminuria, n (%) | 90 (58.1) |
Drugs | |
Hypolipemiant, n (%) | 71 (45.8) |
Aspirin, n (%) | 59 (38.1) |
Diuretic, n (%) | 129 (83.2) |
ACE inhibitor, n (%) | 103 (66.5) |
Angiotensin II receptor antagonist, n (%) | 22 (14.2) |
Calcium channel blocker, n (%) | 65 (41.9) |
Beta-blocker, n (%) | 46 (29.7) |
Blood pressure levels | |
24-h SBP (mmHg) | 135.2 ± 17.4 |
24-h DBP (mmHg) | 81.7 ± 11.0 |
Daytime SBP (mmHg) | 137.4 ± 17.6 |
Daytime DBP (mmHg) | 83.7 ± 11.8 |
Nighttime SBP (mmHg) | 129.0 ± 19.2 |
Nighttime DBP (mmHg) | 75.2 ± 11.8 |
SBP dipping (%) | 5.8 ± 8.3 |
SBP dipping (%) | 10.0 ± 9.1 |
Echocardiographic profile | |
Septal thickness (mm) | 10.1 ± 1.7 |
Wall thickness (mm) | 9.8 ± 2.9 |
LV mass (g) | 203.2 ± 83.4 |
LV mass index (g/m2) | 114.7 ± 47.4 |
Biochemical profile | |
Fasting glycemia (mg/dL) | 96.6 ± 15.6 |
HDL-cholesterol (mg/dL) | 56.8 ± 16.1 |
LDL-cholesterol (mg/dL) | 116.2 ± 88.2 |
Total cholesterol (mg/dL) | 187.3 ± 35.8 |
Triglycerides (mg/dL) | 133.5 ± 78.2 |
Creatinine (mg/dL) | 1.5 ± 1.7 |
Microalbuminuria (µg/min) | 33.6 ± 46.3 |